About lab
Cervical cancer is a global public health subject as it affects women in the reproductive ages, and accounts for the second largest burden among cancer patients worldwide with an unforgiving 50% morta. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagepalaniappan2021-cell-free-modelling-of-second-generation-toehold
Created2026-05-16
Updated2026-05-16
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_mi_r",
"label": "MiR",
"units": "native SBML value",
"default": 1.2e-7,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_mi_r",
"description": "Initial MiR. Sets the initial value of bundled SBML symbol `miR`."
},
{
"name": "initial_antimi_r",
"label": "AntimiR",
"units": "native SBML value",
"default": 1.2e-7,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_antimi_r",
"description": "Initial AntimiR. Sets the initial value of bundled SBML symbol `antimiR`."
},
{
"name": "initial_toehold_dna",
"label": "Toehold DNA",
"units": "native SBML value",
"default": 2.35e-7,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_toehold_dna",
"description": "Initial Toehold DNA. Sets the initial value of bundled SBML symbol `Toehold_DNA`."
},
{
"name": "initial_gfp",
"label": "GFP",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_gfp",
"description": "Initial GFP. Sets the initial value of bundled SBML symbol `GFP`."
},
{
"name": "initial_toehold_rna_cts",
"label": "Toehold RNA CTS",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_toehold_rna_cts",
"description": "Initial Toehold RNA CTS. Sets the initial value of bundled SBML symbol `Toehold_RNA_CTS`."
},
{
"name": "initial_mi_r_antimi_r",
"label": "MiR antimiR",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.initial_mi_r_antimi_r",
"description": "Initial MiR antimiR. Sets the initial value of bundled SBML symbol `miR_antimiR`."
}
],
"outputs": [
{
"name": "mi_r",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.mi_r",
"description": "MiR observable. Maps to SBML symbol `miR`."
},
{
"name": "antimi_r",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.antimi_r",
"description": "AntimiR observable. Maps to SBML symbol `antimiR`."
},
{
"name": "toehold_dna",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.toehold_dna",
"description": "Toehold DNA observable. Maps to SBML symbol `Toehold_DNA`."
},
{
"name": "gfp",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.gfp",
"description": "GFP observable. Maps to SBML symbol `GFP`."
},
{
"name": "toehold_rna_cts",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.toehold_rna_cts",
"description": "Toehold RNA CTS observable. Maps to SBML symbol `Toehold_RNA_CTS`."
},
{
"name": "mi_r_antimi_r",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.mi_r_antimi_r",
"description": "MiR antimiR observable. Maps to SBML symbol `miR_antimiR`."
},
{
"name": "state",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Palaniappan2021 - Cell free modelling of second generation Toehold switches Lab",
"models": [
{
"path": "owned/models/oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model",
"alias": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model",
"provenance": {
"owned_path": "owned/models/oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model_state"
],
"from": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.state"
},
{
"to": [
"visualisation.oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model_summary"
],
"from": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model_species_labels"
],
"from": "oncology_sbml_palaniappan2021_cell_free_modelling_of_second_ge_biomd0000001103_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "Cervical cancer is a global public health subject as it affects women in the reproductive ages, and accounts for the second largest burden among cancer patients worldwide with an unforgiving 50% morta. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.